3rd Mar 2009 09:00
Sinclair Pharma plc
Change of Adviser
3rd March 2009, Godalming, UK: Sinclair Pharma plc ("Sinclair": SPH:L), the international specialty pharma company, are pleased to announce the appointment of Teathers as sole financial adviser and sole broker with immediate effect.
-ends-
For further information please contact:
Sinclair Pharma plc Tel: +44 (0) 1483 410 600
Dr Michael Flynn, CEO
Jerry Randall, CFO
Teathers
Shaun Dobson Tel +44 (0)20 7426 9000
Claes Spång
Notes to Editors:
About Sinclair Pharma Plc www.sinclairpharma.com
Sinclair has proven expertise in acquiring or developing commercially attractive and undervalued products, registering these products and bringing them to market within a short timeframe. Sinclair focuses on niche therapeutic areas and its current portfolio includes products for dermatological conditions and oral health.
"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward-looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward-looking statements due to a variety of factors.
Related Shares:
Sinclair Pharma